TG Therapeutics To Highlight BRIUMVI Data In Adults With Relapsing Forms Of Multiple Sclerosis At 2026 CMSC Annual Meeting
TG Therapeutics Inc TGTX
$40.06
▲ +0.83%
(+$0.33)
Open
$40.14
Prev Close
$39.73
Day Range
$39.36 – $40.50
52W Range
$25.28 – $44.65
Market Cap
$6.08B
P/E (TTM)
12.94
Beta
1.69
EPS (TTM)
$2.87
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1995-12-14 |
| Shares Out. | 153,080,000 |
| Website | tgtherapeutics.com/ ↗ |
| Phone | 13026587581 |
TG Therapeutics Inc is a publicly traded company under the ticker symbol TGTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-05-01)